- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
284 results
1075 Exhibit: Declaration in Support of Petitioners Motion for Pro Hac Vice Admissi...
Document
PGR2017-00022, No. 1075-81 Exhibit - Declaration in Support of Petitioners Motion for Pro Hac Vice Admission of Melinda R Roberts (P.T.A.B. Nov. 29, 2017)
|
|
Cite Document
1074 Exhibit: Declaration in Support of Petitioners Motion for Pro Hac Vice Admissi...
Document
PGR2017-00022, No. 1074-80 Exhibit - Declaration in Support of Petitioners Motion for Pro Hac Vice Admission of James R Tyminski Jr (P.T.A.B. Nov. 29, 2017)
|
|
Cite Document
2018 Exhibit: Exhibit 2018
Document
PGR2017-00022, No. 2018-79 Exhibit - Exhibit 2018 (P.T.A.B. Sep. 29, 2017)
|
|
Cite Document
2005 Exhibit: US Patent App Publication No 20140051669
Document
PGR2017-00022, No. 2005-66 Exhibit - US Patent App Publication No 20140051669 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2014 Exhibit: Goldman Levine, Zoledronic Acid Reclast for Osteoporosis, AM FAM ...
Document
PGR2017-00022, No. 2014-75 Exhibit - Goldman Levine, Zoledronic Acid Reclast for Osteoporosis, AM FAM PHYSICIAN 2008 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2008 Exhibit: Conte, Safety of intravenous and oral bisphosphonates and complian...
Document
PGR2017-00022, No. 2008-69 Exhibit - Conte, Safety of intravenous and oral bisphosphonates and compliance with dosing regimens, THE ONCOLOGIST 2004 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2010 Exhibit: Thar Pharmaceuticals, INVESTOR PRESENTATION, Winter 2015
Document
PGR2017-00022, No. 2010-71 Exhibit - Thar Pharmaceuticals, INVESTOR PRESENTATION, Winter 2015 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2011 Exhibit: Black, Randomised trial of effect of alendronate on risk of fracture in w...
Document
PGR2017-00022, No. 2011-72 Exhibit - Black, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, THE LANCET 1996 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2017 Exhibit: Isinga, Administration Costs of Denosumab and Zoledronic Acid for P...
Document
PGR2017-00022, No. 2017-78 Exhibit - Isinga, Administration Costs of Denosumab and Zoledronic Acid for Postmenopausal Osteoporosis, AM J PHARM BENEFITS 2016 (P.T.A.B. Aug. 23, 201...
|
|
Cite Document
2012 Exhibit: Harris, Effects of Risedronate Treatment on Vertebral and Nonverteb...
Document
PGR2017-00022, No. 2012-73 Exhibit - Harris, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women with Postmenopausal Osteoporosis, JAMA 1999 (P.T.A.B. A...
|
|
Cite Document
2016 Exhibit: US Patent App Publication No 20100215743
Document
PGR2017-00022, No. 2016-77 Exhibit - US Patent App Publication No 20100215743 (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2004 Exhibit: Curriculum vitae for Dr Wargin
Document
PGR2017-00022, No. 2004-65 Exhibit - Curriculum vitae for Dr Wargin (P.T.A.B. Aug. 23, 2017)
|
|
Cite Document
2007 Exhibit: GUIDANCE FOR INDUSTRY ESTIMATING THE MAXIMUM SAFE STA...
Document
PGR2017-00022, No. 2007-68 Exhibit - GUIDANCE FOR INDUSTRY ESTIMATING THE MAXIMUM SAFE STARTING DOSE IN INITIAL CLINICAL TRIALS FOR THERAPEUTICS IN ADULT HEALT...
|
|
Cite Document
1033 Exhibit: McHugh
Document
PGR2017-00022, No. 1033-23 Exhibit - McHugh (P.T.A.B. May. 8, 2017)
|
|
Cite Document
1049 Exhibit: Carbone
Document
PGR2017-00022, No. 1049-36 Exhibit - Carbone (P.T.A.B. May. 8, 2017)
|
|
Cite Document
